Skip to main content
. 2022 Jun 6;159:25. doi: 10.1186/s41065-022-00237-w

Table 2.

Phenotypes of 76 women with hemochromatosis and HFE p.C282Y homozygosity a

Phenotype HLA-A*03 homozygotes, % (n = 16) HLA-A*03 heterozygotes (n = 38) No HLA-A*03, % (n = 22) Value of p
Mean age, y ± 1 SD 49 ± 15 51 ± 12 51 ± 13 0.8227
Mean TS, % ± 1 SD 77 ± 17 75 ± 20 76 ± 19 0.7844
Median SF, µg/L (range) 480 (65, 3468) 444 (34, 5427) 644 (32, 5000) 0.6635
Hemochromatosis arthropathy, % (n) 25.0 (4) 13.2 (5) 22.7 (5) 0.6063
Diabetes, % (n) 18.8 (3) 15.8 (6) 18.2 (4) 0.9357
Hypogonadotropic hypogonadism b, % (n) 0 0 0 1.0000
Cardiomyopathy, % (n) 0 0 0 1.0000
Cirrhosis, % (n) 6.3 (1) 2.6 (1) 1.3 (1) 0.3030
Median FIB-4 index (range) 0.96 (0.52, 4.52) 0.93 (0.43, 5.16) 0.98 (0.44, 2.53) 0.8785
Median APRI (range) 0.22 (0.09, 1.47) 0.24 (0.13, 1.07) 0.24 (0.11, 1.17) 0.9252
Median QFe/age, mg/y (range) 77 (27, 291) 51 (7, 645) 54 (0, 244) 0.4346

a Abbreviations: APRI aspartate aminotransferase-to-platelet ratio, FIB-4 fibrosis-four variables index, HLA human leukocyte antigen, QFe/age is defined as the quotient of quantity of iron removed to achieve iron depletion by age at diagnosis (mg/y); SD standard deviation, SF serum ferritin, TS transferrin saturation

b Testing was indicated in 3 women, none of whom had hypogonadotropic hypogonadism